Volibo 0.2mg belongs to the alpha-glucosidase inhibitor group. Voglibose slows carbohydrate breakdown in the intestine, delaying glucose absorption and helping moderate postprandial blood sugar elevations.

It can be incorporated into type 2 diabetes treatment when controlling glucose after meals is an important therapeutic goal. Diet remains an essential part of managing the condition.

Brand: Volibo

Active Ingredient: Voglibose 0.2mg

Dosage Form: Tablet

Pack Size: 15 tablets

Therapeutic Class: Alpha-glucosidase inhibitor

Administration: Oral

Take with meals as directed by the prescribing professional.